Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | 1034 dni temu
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | 778 dni temu
Japanese Market Significantly Higher

Japanese Market Significantly Higher

The Japanese stock market is trading significantly higher on Wednesday, reversing the losses in the previous session, following the broadly positive cues from Wall Street overnight. The Nikkei 225 is moving above the 50,800 level, with gains in exporters and technology stocks.
RTTNews | 38 minut temu
China Shares Poised To Open In The Green

China Shares Poised To Open In The Green

The China stock market on Tuesday ended the three-day winning streak in which it had collected more than 80 points or 2 percent. The Shanghai Composite Index now sits just shy of the 3,990-point plateau although it may move higher again on Wednesday.
RTTNews | 55 minut temu
Australian Market Modestly Lower

Australian Market Modestly Lower

Australian shares are trading modestly lower on Wednesday, reversing some of the losses in the previous session, with the benchmark S&P/ASX 200 falling well below the 9,000 level, despite the broadly positive cues from Wall Street overnight, with weakness in financial and technology stocks.
RTTNews | 1g 2 minut temu
Tech Shares May Boost Taiwan Stock Market

Tech Shares May Boost Taiwan Stock Market

The Taiwan stock market headed south again on Tuesday, one day after snapping the two-day slide in which it had slumped more than 220 points or 0.8 percent. The Taiwan Stock Exchange now sits just shy of the 27,950-point plateau although it may find renewed support on Wednesday.
RTTNews | 1g 25 minut temu
Singapore Bourse May Extend Winning Streak

Singapore Bourse May Extend Winning Streak

The Singapore stock market has climbed higher in six straight sessions, jumping more than 120 points or 2.9 percent along the way. The Straits Times Index now sits just above the 4,450-point plateau and it may add to its winnings on Wednesday.
RTTNews | 1g 55 minut temu